| scholarly article | Q13442814 |
| P50 | author | Marije Koenders | Q38318056 |
| Martin J Nicklin | Q58684573 | ||
| Shahla Abdollahi-Roodsaz | Q89427855 | ||
| Leo A.B. Joosten | Q89547374 | ||
| Timothy R D J Radstake | Q114341720 | ||
| Isabel Devesa | Q114405418 | ||
| Marleen Heuvelmans-Jacobs | Q114405424 | ||
| P2093 | author name string | Wim B van den Berg | |
| Shizuo Akira | |||
| Mieke F Roelofs | |||
| Fátima Ribeiro-Dias | |||
| P2860 | cites work | In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas | Q24652833 |
| IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis | Q24796707 | ||
| Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells | Q27860460 | ||
| Control of regulatory T cell development by the transcription factor Foxp3 | Q27860489 | ||
| Foxp3 programs the development and function of CD4+CD25+ regulatory T cells | Q27860714 | ||
| Pathogen recognition and innate immunity | Q27861084 | ||
| STAT3 and NF-kappaB signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice | Q28235220 | ||
| Transforming growth factor-beta induces development of the T(H)17 lineage | Q28237370 | ||
| TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells | Q28296956 | ||
| Regulatory T cell lineage specification by the forkhead transcription factor foxp3 | Q28510328 | ||
| A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 | Q29547855 | ||
| Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages | Q29547871 | ||
| Interleukin-12 and the regulation of innate resistance and adaptive immunity | Q29614602 | ||
| Phenotypic and functional features of human Th17 cells | Q29619323 | ||
| The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages | Q33895703 | ||
| Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter | Q33936032 | ||
| The role of different subsets of T regulatory cells in controlling autoimmunity | Q34096248 | ||
| The endoplasmic reticulum-resident heat shock protein Gp96 activates dendritic cells via the Toll-like receptor 2/4 pathway | Q34120383 | ||
| Influence of the indigenous gastrointestinal microbial flora on duodenal alkaline phosphatase activity in mice | Q34171268 | ||
| Toll-like receptor 2 controls expansion and function of regulatory T cells | Q34264024 | ||
| Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis | Q34312767 | ||
| CpG motifs in bacterial DNA and their immune effects | Q34542287 | ||
| Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease | Q34556560 | ||
| Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells | Q34557118 | ||
| IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist | Q35022575 | ||
| Expression and regulation of Toll-like receptor 2 in rheumatoid arthritis synovium | Q35749232 | ||
| CpG DNA inhibits CD4+CD25+ Treg suppression through direct MyD88-dependent costimulation of effector CD4+ T cells | Q35776179 | ||
| The distribution of fibronectin in the pannus in rheumatoid arthritis. | Q36091597 | ||
| Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene | Q36375747 | ||
| Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice | Q36375776 | ||
| The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion | Q36403403 | ||
| TNF-alpha is crucial for the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice | Q37625825 | ||
| Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritides | Q37876840 | ||
| Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1. | Q38594831 | ||
| Toll-like receptor ligands directly promote activated CD4+ T cell survival | Q39442360 | ||
| Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion | Q40590532 | ||
| Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein | Q40609759 | ||
| Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. | Q40733888 | ||
| The extra domain A of fibronectin activates Toll-like receptor 4. | Q40832345 | ||
| Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid arthritis | Q41101140 | ||
| The Toll-like receptor adaptor proteins MyD88 and Mal/TIRAP contribute to the inflammatory and destructive processes in a human model of rheumatoid arthritis | Q42853439 | ||
| Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma | Q44772766 | ||
| Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway | Q45178588 | ||
| IL-10 released by concomitant TLR2 stimulation blocks the induction of a subset of Th1 cytokines that are specifically induced by TLR4 or TLR3 in human dendritic cells | Q45178622 | ||
| Cellular fibronectin in rheumatoid synovium and synovial fluid: a possible factor contributing to lymphocytic infiltration | Q45289702 | ||
| Synovial Epstein-Barr virus infection increases the risk of rheumatoid arthritis in individuals with the shared HLA-DR4 epitope | Q45748463 | ||
| Toll-like receptor-4 signaling mediates hepatic injury and systemic inflammation in hemorrhagic shock | Q46962508 | ||
| Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis | Q47596885 | ||
| TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes | Q47667692 | ||
| A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells | Q47810460 | ||
| Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells | Q47991722 | ||
| Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. | Q52956682 | ||
| Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. | Q53597450 | ||
| Inhibition of Toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis. | Q54435250 | ||
| The diacylated lipopeptide FSL-1 induces TLR2-mediated Th2 responses. | Q54455967 | ||
| TLR9 ligand enhances proliferation of rat CD4+ T cell and modulates suppressive activity mediated by CD4+ CD25+ T cell. | Q54563754 | ||
| Preferential production of the IL-12(p40)/IL-23(p19) heterodimer by dendritic cells from human newborns. | Q54627231 | ||
| Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression | Q59048389 | ||
| Protection against cartilage proteoglycan synthesis inhibition by antiinterleukin 1 antibodies in experimental arthritis | Q68112952 | ||
| A simple sensitive bioassay for interleukin-1 which is unresponsive to 10(3) U/ml of interleukin-2 | Q68819313 | ||
| Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra | Q71098362 | ||
| Antigen-presenting cells containing bacterial peptidoglycan in synovial tissues of rheumatoid arthritis patients coexpress costimulatory molecules and cytokines | Q73092696 | ||
| Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions | Q74179201 | ||
| Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells | Q74285101 | ||
| Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis | Q77890153 | ||
| An interferon-gamma-producing Th1 subset is the major source of IL-17 in experimental autoimmune encephalitis | Q79617034 | ||
| The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells | Q80955813 | ||
| Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma | Q81129108 | ||
| Identification of small heat shock protein B8 (HSP22) as a novel TLR4 ligand and potential involvement in the pathogenesis of rheumatoid arthritis | Q83367358 | ||
| Association of interleukin-18 expression with enhanced levels of both interleukin-1beta and tumor necrosis factor alpha in knee synovial tissue of patients with rheumatoid arthritis | Q94174926 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | toll-like receptor | Q408004 |
| P304 | page(s) | 205-216 | |
| P577 | publication date | 2008-01-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis | |
| P478 | volume | 118 |
| Q37249268 | A new inflammatory cytokine on the block: re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17. |
| Q35220614 | Aberrant interleukin-1 signalling does not increase susceptibility of mice to NOD2-dependent uveitis |
| Q33827644 | Aberrant intestinal microbiota due to IL-1 receptor antagonist deficiency promotes IL-17- and TLR4-dependent arthritis |
| Q37212025 | Activation of TLR4 signaling promotes gastric cancer progression by inducing mitochondrial ROS production |
| Q43258243 | Activation profile of Toll-like receptors of peripheral blood lymphocytes in patients with systemic lupus erythematosus. |
| Q40324590 | Adenovirus-Mediated Small Interfering RNA Targeting TAK1 Ameliorates Joint Inflammation with Collagen-Induced Arthritis in Mice |
| Q41191451 | Aggravation of collagen-induced arthritis by orally administered Porphyromonas gingivalis through modulation of the gut microbiota and gut immune system |
| Q47108321 | Alteration of the intestinal microbiome characterizes preclinical inflammatory arthritis in mice and its modulation attenuates established arthritis. |
| Q39026607 | Altered gut microbiota in RA: implications for treatment |
| Q91757270 | Ameliorating effects of Gö6976, a pharmacological agent that inhibits protein kinase D, on collagen-induced arthritis |
| Q34618018 | Analysis of fecal Lactobacillus community structure in patients with early rheumatoid arthritis |
| Q37060590 | Angiogenesis in rheumatoid arthritis is fostered directly by toll-like receptor 5 ligation and indirectly through interleukin-17 induction |
| Q42156810 | Angiogenic and inflammatory properties of psoriatic arthritis |
| Q38872112 | Arthritis models: usefulness and interpretation |
| Q33358523 | Arthritis susceptibility and the gut microbiome |
| Q35577364 | Autoimmune host-microbiota interactions at barrier sites and beyond |
| Q28828935 | Bartonella quintana lipopolysaccharide (LPS): structure and characteristics of a potent TLR4 antagonist for in-vitro and in-vivo applications |
| Q35997058 | Bifidobacteria Abundance-Featured Gut Microbiota Compositional Change in Patients with Behcet's Disease |
| Q38906815 | Bioactivity in an Aggrecan 32-mer Fragment Is Mediated via Toll-like Receptor 2. |
| Q36993214 | Cell signalling in macrophages, the principal innate immune effector cells of rheumatoid arthritis |
| Q33939577 | Chlamydia pneumoniae infection induced allergic airway sensitization is controlled by regulatory T-cells and plasmacytoid dendritic cells |
| Q36111296 | Chondrogenesis, chondrocyte differentiation, and articular cartilage metabolism in health and osteoarthritis |
| Q28085515 | Clinical Implications of Basic Science Discoveries: Immune Homeostasis and the Microbiome-Dietary and Therapeutic Modulation and Implications for Transplantation |
| Q37983018 | Commensal gut flora and brain autoimmunity: a love or hate affair? |
| Q90176799 | Crosstalk Between Gut Microbiota and Innate Immunity and Its Implication in Autoimmune Diseases |
| Q39379165 | DNA repair and systemic lupus erythematosus |
| Q64237639 | Data-driven multiple-level analysis of gut-microbiome-immune-joint interactions in rheumatoid arthritis |
| Q36091912 | Decreased expression levels of Ifi genes is associated to the increased resistance to spontaneous arthritis disease in mice deficiency of IL-1RA. |
| Q85052737 | Dendritic cells in tolerance induction for the treatment of autoimmune diseases |
| Q35907743 | Depletion of regulatory T cells leads to an exacerbation of delayed-type hypersensitivity arthritis in C57BL/6 mice that can be counteracted by IL-17 blockade |
| Q58998287 | Destructive role of myeloid differentiation factor 88 and protective role of TRIF in interleukin-17-dependent arthritis in mice |
| Q34672043 | Developing the next generation of monoclonal antibodies for the treatment of rheumatoid arthritis |
| Q60954896 | Diet, Microbiota, and Gut Permeability-The Unknown Triad in Rheumatoid Arthritis |
| Q37627725 | Distinct pathways of humoral and cellular immunity induced with the mucosal administration of a nanoemulsion adjuvant. |
| Q51553209 | Divergent impact of Toll-like receptor 2 deficiency on repair mechanisms in healthy muscle versus Duchenne muscular dystrophy. |
| Q38034090 | Do bugs control our fate? The influence of the microbiome on autoimmunity |
| Q36393941 | Does the gut microbiota have a role in type 1 diabetes? Early evidence from humans and animal models of the disease |
| Q35443254 | Does the microbiota play a role in the pathogenesis of autoimmune diseases? |
| Q34595444 | Dynamics of gut microbiota in autoimmune lupus |
| Q46470525 | Dysbiosis Contributes to Arthritis Development via Activation of Autoreactive T Cells in the Intestine |
| Q89403871 | Dysbiosis of oral microbiota and its association with salivary immunological biomarkers in autoimmune liver disease |
| Q64128808 | Dysbiosis of the Gut Microbiota on the Inflammatory Background due to Lack of Suppressor of Cytokine Signalling-1 in Mice |
| Q37224043 | Ecological fitness and strategies of adaptation of Bartonella species to their hosts and vectors. |
| Q36467010 | Endogenous hepatic glucocorticoid receptor signaling coordinates sex-biased inflammatory gene expression |
| Q28384291 | Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1β production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis |
| Q39350274 | Enhanced suppressor of cytokine signaling 3 in arthritic cartilage dysregulates human chondrocyte function |
| Q53309302 | European League against rheumatism - selected presentation and poster a highlights June 11th to 13th 2013. |
| Q91935600 | Examining pathogenic concepts of autoimmune hepatitis for cues to future investigations and interventions |
| Q21128781 | Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis |
| Q28728570 | Exposure to Candida albicans polarizes a T-cell driven arthritis model towards Th17 responses, resulting in a more destructive arthritis |
| Q33614747 | Expression of TLR2, TLR4, and TLR9 in dermatomyositis and polymyositis |
| Q37013881 | Expression of toll-like receptor 4 contributes to corneal inflammation in experimental dry eye disease |
| Q42369219 | Factoring the intestinal microbiome into the pathogenesis of autoimmune hepatitis |
| Q35361098 | Fc gamma receptor IIb on GM-CSF macrophages controls immune complex mediated inhibition of inflammatory signals |
| Q36057301 | Follicular Helper T Cells in Autoimmunity. |
| Q37690561 | Functional profiling of the gut microbiome in disease-associated inflammation |
| Q49917457 | Gastrointestinal and Hepatic Disease in Rheumatoid Arthritis |
| Q35533807 | Gene, environment, microbiome and mucosal immune tolerance in rheumatoid arthritis |
| Q34746729 | Genomic locus on chromosome 1 regulates susceptibility to spontaneous arthritis in mice deficiency of IL-1RA |
| Q41478749 | Germ-free mice deficient of reactive oxygen species have increased arthritis susceptibility |
| Q36322915 | Glycoprotein 96 perpetuates the persistent inflammation of rheumatoid arthritis |
| Q46274080 | Gut Microbiota Perturbations in Reactive Arthritis and Post-Infectious Spondyloarthritis. |
| Q92970959 | Gut Microbiota Regulates Mincle Mediated Activation of Lung Dendritic Cells to Protect Against Mycobacterium tuberculosis |
| Q89717876 | Gut dysbiosis is prevailing in Sjögren's syndrome and is related to dry eye severity |
| Q38839123 | Gut microbiota in autoimmunity: potential for clinical applications |
| Q33622950 | Heat shock protein 96 is elevated in rheumatoid arthritis and activates macrophages primarily via TLR2 signaling |
| Q91890834 | Host-microbiota interactions in rheumatoid arthritis |
| Q38865890 | How the microbiota shapes rheumatic diseases |
| Q48365860 | Human microbiome, infections, and rheumatic disease |
| Q48251828 | IL-10 Deficiency Reveals a Role for TLR2-Dependent Bystander Activation of T Cells in Lyme Arthritis. |
| Q40087819 | IL-17 Production of Neutrophils Enhances Antibacteria Ability but Promotes Arthritis Development During Mycobacterium tuberculosis Infection |
| Q34019620 | IL-17 as a future therapeutic target for rheumatoid arthritis |
| Q33532584 | IL-17 produced during Trypanosoma cruzi infection plays a central role in regulating parasite-induced myocarditis |
| Q37983096 | IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential |
| Q51371242 | Immune Regulation of Toll-Like Receptor 2 Engagement on CD4+ T Cells in Murine Models of Malignant Pleural Effusion. |
| Q28081984 | Immunogenetic control of the intestinal microbiota |
| Q38004933 | Immunoregulation by the gut microbiota |
| Q35909794 | Impact of IL-1 signalling on experimental uveitis and arthritis |
| Q47167934 | Increased expression of Th17 cytokines and interleukin-22 correlates with disease activity in pristane-induced arthritis in rats |
| Q58809182 | Induction of toll-like receptor 2 positive antigen-presenting cells in spleen of pristane-induced arthritis in rats |
| Q37311131 | Induction, function and regulation of IL-17-producing T cells |
| Q37531246 | Infection and autoimmunity: Lessons of animal models |
| Q42134971 | Inflammation and bone destruction in arthritis: synergistic activity of immune and mesenchymal cells in joints |
| Q37657060 | Influence of microbial environment on autoimmunity. |
| Q26765847 | Innate Sensing of the Gut Microbiota: Modulation of Inflammatory and Autoimmune Diseases |
| Q37761419 | Innate immunity and rheumatoid arthritis |
| Q38161937 | Innate immunity in systemic sclerosis pathogenesis |
| Q37595776 | Innate receptors and microbes in induction of autoimmunity |
| Q38240851 | Insights into the Relationship between Toll Like Receptors and Gamma Delta T Cell Responses |
| Q95320368 | Interaction between microbiota and immunity in health and disease |
| Q87628563 | Interleukin-17 increases the expression of Toll-like receptor 3 via the STAT3 pathway in rheumatoid arthritis fibroblast-like synoviocytes |
| Q41692834 | Intestinal Dysbiosis and Rheumatoid Arthritis: A Link between Gut Microbiota and the Pathogenesis of Rheumatoid Arthritis. |
| Q38757039 | Intestinal dysbiosis and probiotic applications in autoimmune diseases. |
| Q37943809 | Intrinsic danger: activation of Toll-like receptors in rheumatoid arthritis |
| Q37686081 | Invariant natural killer T cells in rheumatic disease: a joint dilemma |
| Q35609376 | Investigation of the differential potentials of TLR agonists to elicit uveitis in mice |
| Q37619719 | Lessons from animal models of arthritis over the past decade |
| Q34802780 | Ligation of TLR7 by rheumatoid arthritis synovial fluid single strand RNA induces transcription of TNFα in monocytes |
| Q90193988 | Linkage of Periodontitis and Rheumatoid Arthritis: Current Evidence and Potential Biological Interactions |
| Q94672157 | Linking gut microbiota with the human diseases |
| Q44389872 | Lipopolysaccharide increases the incidence of collagen-induced arthritis in mice through induction of protease HTRA-1 expression |
| Q42045687 | Local interleukin-1-driven joint pathology is dependent on toll-like receptor 4 activation |
| Q38008340 | Macrophages in synovial inflammation |
| Q59794332 | Mangosteen ethanol extract alleviated the severity of collagen-induced arthritis in rats and produced synergistic effects with methotrexate |
| Q36013705 | Mast Cells are Important Modifiers of Autoimmune Disease: With so Much Evidence, Why is There Still Controversy? |
| Q38673425 | Mechanisms involved in triggering rheumatoid arthritis |
| Q40227012 | Microbial infection-induced expansion of effector T cells overcomes the suppressive effects of regulatory T cells via an IL-2 deprivation mechanism |
| Q33572468 | Microbiome and mucosal inflammation as extra-articular triggers for rheumatoid arthritis and autoimmunity |
| Q35762027 | Microbiome in Inflammatory Arthritis and Human Rheumatic Diseases. |
| Q36626681 | Microbiota and autoimmunity |
| Q33754038 | Microbiota in T-cell homeostasis and inflammatory diseases |
| Q60955353 | Microbiota in the Gastrointestinal Tract |
| Q47807913 | Model answers: Rational application of murine models in arthritis research |
| Q58788272 | Modulation of Apoptosis by Cytotoxic Mediators and Cell-Survival Molecules in Sjögren's Syndrome |
| Q26752055 | Molecular Insight into Gut Microbiota and Rheumatoid Arthritis |
| Q84474094 | Mutations in the IL1RN locus lead to autoinflammation |
| Q87450541 | Mycobacterium tuberculosis promotes arthritis development through Toll-like receptor 2 |
| Q89517312 | Natural and Induced Tolerogenic Dendritic Cells |
| Q38673434 | Ncf1 polymorphism reveals oxidative regulation of autoimmune chronic inflammation |
| Q36437284 | Negative regulation of TLR signaling in myeloid cells--implications for autoimmune diseases |
| Q39181948 | Nitric oxide boosts TLR-4 mediated lipocalin 2 expression in chondrocytes. |
| Q58547042 | Oral Administration of Porphyromonas gingivalis Alters the Gut Microbiome and Serum Metabolome |
| Q92579565 | Osteoarthritis patients with high haemoglobin A1c have increased Toll-like receptor 4 and matrix metalloprotease-13 expression in the synovium |
| Q34258870 | Osteoarthritis: a disease of the joint as an organ |
| Q58809183 | Overexpression of Toll-Like Receptor 3 in Spleen is Associated with Experimental Arthritis in Rats |
| Q28084262 | Pattern recognition receptors as potential therapeutic targets in inflammatory rheumatic disease |
| Q35125382 | Peptide-pulsed dendritic cells have superior ability to induce immune-mediated tissue destruction compared to peptide with adjuvant |
| Q46547727 | Piperlongumine Suppresses Dendritic Cell Maturation by Reducing Production of Reactive Oxygen Species and Has Therapeutic Potential for Rheumatoid Arthritis |
| Q58653666 | Possible Association between Th1 Immune Polarization and Epithelial Permeability with Toll-Like Receptors 2 Dysfunction in the Pathogenesis of the Recurrent Aphthous Ulceration |
| Q38267948 | Pound the alarm: danger signals in rheumatic diseases |
| Q38036102 | Pre-rheumatoid arthritis: predisposition and transition to clinical synovitis |
| Q37150726 | Primer: Toll-like receptor signaling pathways--what do rheumatologists need to know? |
| Q59645646 | Pro-inflammatory action of Candida albicans DNA in zymosan-induced arthritis |
| Q33349475 | Programming dendritic cells to induce T(H)2 and tolerogenic responses |
| Q29619978 | Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis |
| Q36178278 | Regulation of TH17 cell differentiation by innate immune signals |
| Q26781449 | Relationship between intestinal microbiota and colorectal cancer |
| Q94412802 | Reply |
| Q35609406 | Reply: To PMID 25319745 |
| Q58801064 | Retinoic Acid, Leaky Gut, and Autoimmune Diseases |
| Q37998396 | Revisiting the old link between infection and autoimmune disease with commensals and T helper 17 cells |
| Q39362038 | Role of Gut Microbiota in Rheumatoid Arthritis |
| Q36134548 | Role of proopiomelanocortin-derived peptides and their receptors in the osteoarticular system: from basic to translational research |
| Q37145101 | Role of the Gut Microbiome in Modulating Arthritis Progression in Mice |
| Q34036490 | Role of the gut microbiota in immunity and inflammatory disease |
| Q26829755 | Role of viruses and bacteria-virus interactions in autoimmunity |
| Q37364345 | S100A8/A9, a potent serum and molecular imaging biomarker for synovial inflammation and joint destruction in seronegative experimental arthritis |
| Q26773130 | SLE: Another Autoimmune Disorder Influenced by Microbes and Diet? |
| Q35623130 | Sensors of the innate immune system: their link to rheumatic diseases |
| Q28080459 | Sexual dimorphism in autoimmunity |
| Q37021626 | Shaping the (auto)immune response in the gut: the role of intestinal immune regulation in the prevention of type 1 diabetes |
| Q47208021 | Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss. |
| Q35945721 | Spinal TLR4 mediates the transition to a persistent mechanical hypersensitivity after the resolution of inflammation in serum-transferred arthritis |
| Q91709946 | Supplementation of diet with non-digestible oligosaccharides alters the intestinal microbiota, but not arthritis development, in IL-1 receptor antagonist deficient mice |
| Q64100381 | Synbiotic Supplementation May Relieve Anterior Uveitis, an Ocular Manifestation in Behcet’s Syndrome |
| Q37957689 | TLR-dependent T cell activation in autoimmunity. |
| Q55604928 | TLR10 and NFKBIA contributed to the risk of hip osteoarthritis: systematic evaluation based on Han Chinese population. |
| Q38172423 | TLR2 and TLR4 in autoimmune diseases: a comprehensive review |
| Q36775416 | TLR2 deletion promotes arthritis through reduction of IL-10 |
| Q37000362 | TLR2/4 deficiency prevents oxygen-induced vascular degeneration and promotes revascularization by downregulating IL-17 in the retina |
| Q36633174 | TLR4-mediated IL-12 production enhances IFN-γ and IL-1β production, which inhibits TGF-β production and promotes antibody-induced joint inflammation |
| Q36733882 | TLR5, a novel and unidentified inflammatory mediator in rheumatoid arthritis that correlates with disease activity score and joint TNF-α levels |
| Q38781354 | TLRs, future potential therapeutic targets for RA. |
| Q38106621 | Targeting inflammasomes in rheumatic diseases |
| Q37686348 | Th17 cytokines and arthritis |
| Q40110959 | Th17 response and inflammatory autoimmune diseases |
| Q38068964 | Th22 and related cytokines in inflammatory and autoimmune diseases |
| Q26741414 | The Gut Microbiota in Immune-Mediated Inflammatory Diseases |
| Q38819986 | The Microbiome: a Revolution in Treatment for Rheumatic Diseases? |
| Q40215319 | The aggravation of arthritis by periodontitis is dependent of IL-17 receptor A activation. |
| Q37516563 | The biological and clinical importance of the 'new generation' cytokines in rheumatic diseases |
| Q57070010 | The contribution of the gut microbiome to neurodevelopment and neuropsychiatric disorders |
| Q38993207 | The evidence for microbiome manipulation in inflammatory arthritis |
| Q34024073 | The immune system and the gut microbiota: friends or foes? |
| Q39029106 | The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting |
| Q37968302 | The influence of the microbiota on type-1 diabetes: on the threshold of a leap forward in our understanding |
| Q33754027 | The interplay between host immune cells and gut microbiota in chronic inflammatory diseases |
| Q89544573 | The involvement of Toll-like receptor 9 in the pathogenesis of erosive autoimmune arthritis |
| Q35747705 | The lung may play a role in the pathogenesis of rheumatoid arthritis |
| Q36038992 | The metabolic role of the gut microbiota in health and rheumatic disease: mechanisms and interventions |
| Q52715835 | The microbiome and autoimmunity: a paradigm from the gut-liver axis. |
| Q35743863 | The microbiome and rheumatoid arthritis |
| Q39001907 | The microbiome-metabolome crosstalk in the pathogenesis of respiratory fungal diseases |
| Q37214491 | The multiple facets of toll-like receptors in transplantation biology |
| Q36555344 | The novel adipokine progranulin counteracts IL-1 and TLR4-driven inflammatory response in human and murine chondrocytes via TNFR1. |
| Q35277785 | The potential impact of the pulmonary microbiome on immunopathogenesis of Aspergillus-related lung disease |
| Q42622426 | The potential importance of Toll-like receptors in ankylosing spondylitis |
| Q42932963 | The proteasome inhibitor bortezomib drastically affects inflammation and bone disease in adjuvant-induced arthritis in rats |
| Q26860722 | The role of gut microbiota in immune homeostasis and autoimmunity |
| Q50072788 | The role of gut microbiota in the pathogenesis of rheumatic diseases |
| Q38320224 | The role of innate immunity in osteoarthritis: when our first line of defense goes on the offensive |
| Q30371308 | The role of regulatory T cells in atopic dermatitis. |
| Q36024641 | The role of synovitis in osteoarthritis pathogenesis |
| Q50134012 | The role of the gut microbiome in systemic inflammatory disease. |
| Q37601579 | The role of toll-like receptors in rheumatoid arthritis |
| Q36955377 | The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis |
| Q36036277 | The struggle within: microbial influences on colorectal cancer. |
| Q36640360 | Therapeutic efficacy of Tyro3, Axl, and Mer tyrosine kinase agonists in collagen-induced arthritis |
| Q35478520 | Time for a gut check: evidence for the hypothesis that HLA-B27 predisposes to ankylosing spondylitis by altering the microbiome |
| Q28567867 | Toll-like receptor 3 upregulation in macrophages participates in the initiation and maintenance of pristane-induced arthritis in rats |
| Q33999768 | Toll-like receptor 4 is involved in inflammatory and joint destructive pathways in collagen-induced arthritis in DBA1J mice |
| Q42141300 | Toll-like receptor 4 signaling leads to severe fungal infection associated with enhanced proinflammatory immunity and impaired expansion of regulatory T cells. |
| Q35157400 | Toll-like receptor mediated modulation of T cell response by commensal intestinal microbiota as a trigger for autoimmune arthritis |
| Q34015433 | Toll-like receptor signaling: a potential link among rheumatoid arthritis, systemic lupus, and atherosclerosis |
| Q37859678 | Toll-like receptor signaling: common pathways that drive cardiovascular disease and rheumatoid arthritis |
| Q87326859 | Toll-like receptor-4 signaling: a new potential therapeutic pathway for rheumatoid arthritis |
| Q38952668 | Toll-like receptor-mediated immune responses in intestinal macrophages; implications for mucosal immunity and autoimmune diseases |
| Q39546550 | Toll-like receptors 4 and 9 are responsible for the maintenance of the inflammatory reaction in canine steroid-responsive meningitis-arteritis, a large animal model for neutrophilic meningitis |
| Q37616217 | Toll-like receptors and NOD-like receptors in rheumatic diseases |
| Q38832613 | Toll-like receptors and chronic inflammation in rheumatic diseases: new developments |
| Q36940639 | Toll-like receptors as therapeutic targets for autoimmune connective tissue diseases |
| Q37868069 | Toll-like receptors in rheumatic diseases: are we paying a high price for our defense against bugs? |
| Q37066063 | Toll/Interleukin-1 Receptor Domain Derived from TcpC (TIR-TcpC) Ameliorates Experimental Autoimmune Arthritis by Down-modulating Th17 Cell Response |
| Q33359549 | Tracing functional antigen-specific CCR6 Th17 cells after vaccination |
| Q37632475 | Translational mini-review series on Th17 cells: are T helper 17 cells really pathogenic in autoimmunity? |
| Q37632479 | Translational mini-review series on Th17 cells: induction of interleukin-17 production by regulatory T cells. |
| Q42790894 | Trapped in a vicious loop: Toll-like receptors sustain the spontaneous cytokine production by rheumatoid synovium |
| Q58601804 | Tyro3/Axl/Mertk-deficient mice develop bone marrow edema which is an early pathological marker in rheumatoid arthritis |
| Q55031814 | VIPER regulates naive T cell activation and effector responses: Implication in TLR4 associated acute stage T cell responses. |
| Q33662199 | When and where does inflammation begin in rheumatoid arthritis? |
| Q58602514 | Young and aged TLR4 deficient mice show sex-dependent enhancements in spatial memory and alterations in interleukin-1 related genes |
| Q35210622 | ZAP-70 genotype disrupts the relationship between microbiota and host, leading to spondyloarthritis and ileitis in SKG mice. |
Search more.